• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Shiel

Anonymous board for Shiel
Replies
5
Views
2K
anonymous
Replies
103
Views
24K
anonymous
Replies
1
Views
1K
anonymous
Replies
92
Views
14K
anonymous
Replies
300
Views
37K
anonymous
Replies
52
Views
8K
anonymous
  • Locked
Replies
7K
Views
658K